Patent Number: 8,815,924

Title: Heterocyclic carbonyl compounds

Abstract: Novel heterocyclic compounds of the formula (I), in which R.sup.1, D, W, T and T' have the meanings indicated in Claim 1, are SGK inhibitors and can be used for the treatment of SGK-induced diseases and conditions, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, generally in fibroses and inflammatory processes of any type.

Inventors: Dorsch; Dieter (Ober-Ramstadt, DE), Gericke; Rolf (Seeheim-Jugenheim, DE), Mederski; Werner (Zwingenberg, DE), Beier; Norbert (Reinheim, DE), Lang; Florian (Tuebingen, DE)

Assignee: Merck Patent GmbH

International Classification: A61K 31/421 (20060101); A61K 31/422 (20060101); C07D 307/34 (20060101); C07D 231/56 (20060101); C07D 233/54 (20060101); C07D 413/02 (20060101); C07D 413/00 (20060101); A61K 31/341 (20060101); A61K 31/4178 (20060101); A61K 31/416 (20060101)

Expiration Date: 8/26/12018